AI GRAND ROUNDS

Authors: GEMINI (RESIDENT), GROK (ATTENDING), CHATGPT (EXPERT) & ANUPAM SINGH MD (Human in loop)

Department of Medicine, Santosh Medical College.

Click here for App | Agentic Grand Rounds Index

Round 1

User:

STAGE 1: Initial Presentation & Baseline Workup

A 34-year-old woman presents to the outpatient clinic for a routine health check-up. She is completely asymptomatic and takes no medications, supplements, or traditional remedies. Physical examination is entirely unremarkable: pulse 74/min, blood pressure 118/76 mmHg, with no edema or signs of volume overload.

Routine biochemistry reveals an incidental finding of hyperkalemia:
- Serum Potassium (K+): 5.8 mmol/L (repeated on a free-flowing, non-tourniquet, non-hemolyzed venous sample: 5.9 mmol/L; plasma potassium: 5.7 mmol/L, ruling out pseudohyperkalemia)
- Serum Sodium (Na+): 141 mmol/L
- Serum Chloride: 104 mmol/L
- Serum Bicarbonate (HCO3-): 25 mmol/L (normal anion gap, no metabolic acidosis)
- Blood Urea Nitrogen: 12 mg/dL
- Serum Creatinine: 0.68 mg/dL (eGFR CKD-EPI: 121 mL/min/1.73 m2)
- Fasting Blood Glucose: 92 mg/dL
- Serum Calcium: 9.4 mg/dL, Magnesium: 2.1 mg/dL
- 12-lead ECG: Normal sinus rhythm, normal PR interval, narrow QRS, no peaked T-waves or conduction abnormalities.

Resident and Attending: Please evaluate this case of asymptomatic, normotensive hyperkalemia with completely preserved renal function and normal acid-base status. What is your diagnostic framework, what major pathophysiological categories should be considered, and what targeted investigations would you order next?

Resident:

Hello, Chief Resident here.

Key Findings:
* 34-year-old asymptomatic, normotensive female.
* Confirmed true hyperkalemia (K+ 5.8–5.9 mmol/L; plasma confirmed).
* Normal GFR (121 mL/min/1.73m²), normal bicarbonate (25 mmol/L), and normal ECG.

Differential Diagnoses:
1. Isolated Hypoaldosteronism / Mineralocorticoid Deficiency: 40% — Selective impaired aldosterone synthesis or secretion without renal insufficiency or overt acidosis.
2. Familial Pseudohyperkalemia (e.g., Red Cell Transporter Defect): 25% — Temperature-dependent K+ leakage out of RBCs post-venipuncture, which can persist even in plasma if not handled at 37°C.
3. Gordon Syndrome (Familial Hyperkalemic Hypertension - Early/Incomplete): 20% — WNK kinase mutation causing enhanced distal nephron K+ reabsorption before hypertension or hyperchloremic acidosis fully manifests.
4. Early Primary Adrenal Insufficiency (Addison's Disease): 15% — Isolated mineralocorticoid loss can precede overt glucocorticoid deficiency and hyperpigmentation.

Recommended Prioritized Investigations:
1. Paired Serum Aldosterone and Plasma Renin Activity (PRA).
2. 8 AM Serum Cortisol and Plasma ACTH.
3. Spot Urine Potassium, Sodium, and Osmolality (to assess renal K+ excretion / TTKG).
4. Temperature-controlled Plasma Potassium Test (immediate processing at 37°C vs room temperature to rule out red cell membrane defects).

Attending:

Hello Attending Consultant here

Top 3 DDx:
1. Isolated hypoaldosteronism (aldosterone synthase defect or hyporeninemic)
2. Familial pseudohyperkalemia (hereditary xerocytosis/RBC leak)
3. Incomplete Gordon syndrome (PHA2; WNK1/4 or KLHL3 variant)

Critique/Improvements (6 points):
- Drop early Addison’s to <5% probability: normal Na, HCO3, BP and no symptoms make isolated mineralocorticoid failure far more likely than evolving PAI.
- Add 24-h urine K and TTKG/UK/UCr ratio immediately—low TTKG (<5–6) confirms renal retention before hormone assays.
- Order aldosterone/PRA upright and after 2 h ambulation; ratio >30 with low aldo points to hyporeninemic hypoaldosteronism.
- Include CBC + smear + CK to exclude occult hemolysis or rhabdomyolysis contributing to K load.
- Genetic panel (WNK, CUL3, KLHL3, ABCB6) only after biochemical confirmation of low aldo/renin or temp-dependent leak.
- Repeat K on arterial blood gas analyzer at 37 °C to definitively exclude residual pseudohyperkalemia.
- No empiric fludrocortisone or thiazide until axis defined; risk of iatrogenic HTN/hypokalemia.

Expert:

Hello, Expert Clinician here.

Best current unifying diagnosis: Persistent isolated hyperkalemia from impaired distal renal potassium secretion, most likely an aldosterone-axis abnormality, although a temperature-dependent red-cell potassium leak remains important to exclude.

Key pivot: Hyperkalemia is reproducible despite preserved GFR, normal bicarbonate, normotension, and no exogenous contributors. This shifts attention from renal failure/acidosis toward aldosterone signaling, distal sodium delivery, or unusual preanalytic/cellular causes.

Top differentials
1. Isolated hypoaldosteronism or aldosterone resistance: Fits reduced renal potassium excretion; normal sodium and bicarbonate do not exclude an early/selective defect.
2. Familial pseudohyperkalemia: Fits an asymptomatic young patient with otherwise normal physiology. Plasma elevation does not exclude temperature- or storage-dependent RBC leakage.
3. Gordon syndrome (PHA-II): Causes hyperkalemia via enhanced distal sodium-chloride reabsorption, but normal blood pressure, chloride, and bicarbonate make classic disease less likely.
4. Primary adrenal insufficiency: Less likely without hypotension, hyponatremia, symptoms, or acidosis.
5. Transcellular release/shift: Exclude occult hemolysis, thrombocytosis/leukocytosis, muscle injury, or insulin deficiency.

Next move: Obtain immediately analyzed whole-blood potassium, CBC, CK, glucose, urine potassium/sodium/creatinine and osmolality, plus paired renin and aldosterone under standardized conditions; check morning cortisol/ACTH if aldosterone is low.

Teaching pearl: Normal GFR does not guarantee normal distal potassium secretion.

Round 2

User:

STAGE 2: Endocrine Workup & Urinary Electrolyte Paradox

Targeted secondary investigations to assess adrenal function, the renin-angiotensin-aldosterone axis, and renal potassium handling reveal the following:

Adrenal & Renin-Aldosterone Profile (measured in seated position):
- Morning 8 AM Serum Cortisol: 16.4 mcg/dL (normal adrenal reserve, ruling out Addison disease)
- Plasma Renin Activity (PRA): < 0.1 ng/mL/h (profoundly suppressed, reference 0.6–4.0)
- Plasma Aldosterone Concentration (PAC): < 1.0 ng/dL (undetectable / suppressed, reference 3.0–30.0)
- Serum Aldosterone-to-Renin Ratio: Not calculable due to dual suppression.

24-Hour Urine Electrolyte & Osmolality Studies:
- 24-hour Urine Volume: 3.2 L/day
- 24-hour Urinary Sodium Excretion: 1800 mmol/day (equivalent to ~105 g/day of NaCl)
- 24-hour Urinary Potassium Excretion: 306 mmol/day (equivalent to ~12 g/day of elemental K+)
- Transtubular Potassium Gradient (TTKG): 7.8
- Urinary Fractional Excretion of Potassium (FE_K): 28% (robust kaliuresis despite hypoaldosteronism)
- Urine pH: 6.2, Urine toxicology: Negative for diuretics, laxatives, or NSAIDs.

Resident, Attending, and Expert: We have a striking physiological paradox: severe dual suppression of renin AND aldosterone in the setting of hyperkalemia, accompanied by extraordinary, massive urinary sodium and potassium excretion. How do you explain the suppression of aldosterone when hyperkalemia is normally a potent direct secretagogue of the adrenal zona glomerulosa? How is the kidney maintaining substantial kaliuresis despite absent aldosterone? What clinical condition or exposure produces this profile?

Resident:

Hello, Chief Resident here.

Key Updated Findings:
* Suppressed PRA (<0.1 ng/mL/h) and Aldosterone (<1.0 ng/dL) with normal adrenal reserve (Cortisol 16.4 mcg/dL).
* Massive 24-hour urinary excretion: Sodium (1800 mmol/day) and Potassium (306 mmol/day).
* High distal sodium delivery and tubular flow explain preserved kaliuresis (TTKG 7.8, FE_K 28%) despite absent aldosterone.

Differential Diagnoses:
1. Exogenous Potassium & Sodium Ingestion (e.g., "Lite Salt" / KCl substitutes): 65% — Massive urine Na and K directly reflect heavy dietary or supplemental intake; volume expansion suppresses the renin-aldosterone axis while intake exceeds renal clearance.
2. Apparent Mineralocorticoid Excess (AME) / 11β-HSD2 Inhibition (Licorice/Herbal Ingestion): 20% — Excessive MR activation suppresses renin and aldosterone, driving distal K loss; hyperkalemia manifests if oral K loading co-occurs.
3. Surreptitious Ingestion or Specimen Handling Artifact: 15% — Hidden supplement loading or severe urine/blood collection artifact.

Recommended Prioritized Tests:
1. Targeted history regarding "Lite Salt", potassium-enriched foods, herbal teas, or licorice.
2. Urinary Free Cortisol-to-Cortisone ratio (to evaluate 11β-HSD2 inhibition).
3. Repeat spot urine sodium and potassium to confirm true steady-state output.
4. Screen for exogenous cardiotonic glycosides (e.g., digoxin).

Attending:

Hello Attending Consultant here

Top 3 DDx:
1. Massive exogenous NaCl + KCl intake (e.g., salt substitutes/"Lite Salt")
2. Licorice/AME with concurrent K loading (11β-HSD2 inhibition)
3. Factitious/surreptitious mineral loading or collection artifact

Critique/Improvements (6 points):
- Elevate exogenous intake to >80%: dual RAAS suppression + extreme natriuresis/kaliuresis (1800/306 mmol/d) is pathognomonic for volume-expanded overload exceeding secretory capacity; hyperkalemia persists as intake transiently outstrips even high FE_K.
- Downgrade AME/licorice: typically causes hypokalemia, not hyperkalemia, unless massive concurrent K load; check UFC/UFE ratio only if history positive.
- Demand quantified dietary recall + pharmacy/herbal screen immediately—urine values imply >100 g NaCl + 12 g K daily.
- Recalculate TTKG on simultaneous plasma/urine osmolality; 7.8 is inappropriately low for K 5.9, confirming relative aldosterone deficiency from suppression.
- Add plasma volume/renin stimulation test (furosemide or upright) only after intake cessation to confirm reversibility.
- No fludrocortisone trial: will worsen volume expansion; observe K after supervised low-Na/K diet.

Expert:

Hello, Expert Clinician here.

Best unifying diagnosis: Massive exogenous sodium and potassium loading—most plausibly deliberate/surreptitious ingestion of NaCl plus KCl-containing salt substitute (“lite salt”), with volume-mediated suppression of the renin–aldosterone system.

Physiologic explanation: Urinary excretion approximates intake at steady state: 1,800 mmol sodium equals about 105 g NaCl/day, and 306 mmol potassium equals about 12 g elemental potassium/day. Extreme sodium loading expands effective circulating volume, profoundly suppressing renin and angiotensin II; this can markedly blunt zona glomerulosa aldosterone secretion despite potassium’s direct stimulatory effect. The potassium burden can still exceed excretory capacity, producing mild hyperkalemia.

Substantial kaliuresis persists because massive sodium delivery and high tubular flow promote distal potassium secretion through aldosterone-independent flow-sensitive pathways and a favorable lumen-negative gradient. Thus, high urinary potassium does not exclude potassium-loading hyperkalemia.

Less likely: Licorice/apparent mineralocorticoid excess or exogenous mineralocorticoid activity would explain low renin/aldosterone but usually causes hypertension and hypokalemia. Collection adulteration remains possible given the extraordinary values.

Key next move: Conduct a supervised metabolic-ward dietary washout with controlled sodium/potassium intake, observed urine collection, and serial potassium, renin, and aldosterone measurements; obtain a focused, nonjudgmental exposure history.

Teaching pearl: Twenty-four-hour urinary electrolyte excretion is a powerful quantitative dietary “receipt.”

Round 3

User:

STAGE 3: Dietary Anamnesis & Mechanistic Reveal

A detailed dietary and nutritional anamnesis resolves the mystery of the massive urinary electrolyte excretion:

The patient describes a longstanding habitual dietary pattern:
- She consumes copious quantities of fresh raw tomatoes, cucumbers, radish, and seasonal salad vegetables.
- Crucially, she eats them using the culinary habit of "à la croque-au-sel" — dipping each raw vegetable piece directly into generous heaps of table salt before consumption.
- Estimated daily intake: ~100 grams of table salt (NaCl) per day (1700–1800 mmol Na+) combined with ~12 grams of dietary potassium per day (~300 mmol K+ from massive raw tomato and vegetable volume).

Expert Clinician and Panel:
1. Dissect the precise molecular and physiological tug-of-war in the adrenal cortex between extreme sodium/volume loading (which suppresses renin and stimulates ANP) versus hyperkalemia (which depolarizes glomerulosa cells). Why did the sodium load completely override the potassium-driven stimulus for aldosterone synthase (CYP11B2)?
2. Detail the aldosterone-independent mechanisms of distal nephron potassium secretion that prevented life-threatening hyperkalemia despite suppressed mineralocorticoids (role of distal sodium delivery, high tubular flow rate, ENaC, BK channels, and mTORC2-SGK1 signaling).

Resident:

Hello, Chief Resident here.

Key Updated Findings:
* Dietary confirmation: ~100g NaCl (1,800 mmol Na+) + ~12g dietary K+ (300 mmol K+) daily via salted raw vegetables.

Diagnoses:
1. Exogenous Massive Sodium and Potassium Loading: 95% — Explains the profound RAAS suppression alongside massive kaliuresis and mild hyperkalemia.
2. Subclinical Distal Nephron Secretory Defect: 5% — Unlikely given robust fractional excretion.

Physiologic Dissection:
1. Adrenal Suppression: Extreme volume expansion suppresses Angiotensin II and releases ANP. ANP binds to NPR-A, increasing cGMP and opening $K^+$ channels. This hyperpolarizes zona glomerulosa membranes, inhibiting voltage-gated $Ca^{2+}$ channels. This hyperpolarization completely overrides $K^+$-induced depolarization, downregulating CYP11B2 (aldosterone synthase) and suppressing aldosterone synthesis.
2. Aldosterone-Independent Kaliuresis: Hyperkalemia was blunted because massive distal $Na^+$ delivery fuels ENaC reabsorption, sustaining a lumen-negative gradient. Simultaneously, high tubular flow rate creates fluid shear stress that physically bends primary cilia, triggering mTORC2 activation and opening high-conductance, flow-sensitive BK (Maxi-K) channels. This drives massive flow-dependent potassium secretion without mineralocorticoids.

Next Steps:
Educate patient to normalize dietary NaCl/K+ intake; re-evaluate serum $K^+$, PRA, and aldosterone in 2–4 weeks to confirm full biochemical recovery.

Attending:

Hello Attending Consultant here

Top 3 DDx:
1. Massive dietary NaCl + K+ overload (croque-au-sel habit)
2. Residual volume-expanded hyporeninemic hypoaldosteronism
3. Occult BK-channel gain-of-function (unlikely)

Critique/Improvements (6 points):
- Confirm diagnosis at >95%; resident correctly prioritizes intake cessation over further testing.
- Adrenal tug-of-war: Volume/ANP-cGMP hyperpolarizes glomerulosa via Kir channels, clamping Ca2+ influx and extinguishing CYP11B2 transcription despite K+-driven depolarization—Ang II absence is decisive.
- Kaliuresis mechanics: High distal Na delivery sustains ENaC-driven lumen-negative potential; flow shear activates BK/Maxi-K via mTORC2-SGK1 and ROMK upregulation, fully aldosterone-independent.
- Add supervised 7-day low-Na/K diet with serial K/PRA/aldo to document full reversibility.
- Quantify 24-h urine post-washout to prove intake was sole driver.
- Screen for hypertension/edema risk if habit resumes; no need for genetics or UFC ratio.
- Educate on salt-substitute risks; discharge with K recheck only.

Expert:

Hello, Expert Clinician here.

Unifying diagnosis: Diet-induced sodium/volume expansion with simultaneous extreme potassium loading, causing reversible hyporeninemic hypoaldosteronism and flow-dependent kaliuresis.

Adrenal tug-of-war: Hyperkalemia normally inhibits zona-glomerulosa potassium channels, depolarizing the membrane, opening voltage-gated calcium channels, and activating calcium-dependent CYP11B2 transcription. Here, massive sodium intake expanded effective circulating volume, nearly abolished renin–angiotensin II signaling, and increased atrial natriuretic peptide. Loss of angiotensin-II’s synergistic calcium/steroidogenic signal, combined with ANP–NPR-A–cGMP inhibition of steroidogenesis, dominated the potassium signal, suppressing CYP11B2 and aldosterone. This is an extreme, reversible physiologic response—not primary adrenal failure.

Why potassium remained only mildly elevated: Enormous sodium delivery and 3.2-L/day flow reached the collecting nephron. Basal ENaC-mediated sodium uptake generated a lumen-negative potential favoring potassium secretion through ROMK and especially flow-sensitive BK channels. Shear stress and increased intracellular calcium activate BK; mTORC2–SGK1 signaling can preserve ENaC/secretory-channel activity even without aldosterone. Thus, urinary potassium was high but still insufficient to fully match intake.

AME/licorice is unlikely because it typically causes hypertension and hypokalemia.

Next move: Supervised sodium/potassium normalization with serial serum potassium, renin/aldosterone, and 24-hour urine electrolytes.

Teaching pearl: High urinary potassium may indicate massive intake-driven excretion, not adequate potassium balance.

Round 4

User:

STAGE 4: Management, Clinical Course & High-Yield Takeaways

The patient was counseled regarding dietary modification:
- Extreme salt dipping was discontinued, and vegetable intake was moderated to standard recommended quantities.
- Within 7 days of adopting a normal balanced diet (~5 g NaCl/day, ~3 g K+/day):
* Serum Potassium normalized to 4.3 mmol/L.
* Serum Sodium: 139 mmol/L, Creatinine: 0.65 mg/dL.
* 24-hour Urinary Sodium dropped to 142 mmol/day; 24-hour Urinary Potassium dropped to 58 mmol/day.
* Repeat Plasma Renin Activity: 1.8 ng/mL/h (normalized).
* Repeat Plasma Aldosterone: 11.2 ng/dL (normalized).

Panel: Please provide the final clinical synthesis and key high-yield takeaways for clinicians, hospitalists, and nephrologists regarding extreme dietary electrolyte loading, the hierarchy of renin-aldosterone regulation, and aldosterone-independent renal potassium homeostasis.

Resident:

Hello, Chief Resident here.

Key Updated Findings & Final Diagnosis:
* Complete normalization of serum potassium (4.3 mmol/L), PRA (1.8 ng/mL/h), and plasma aldosterone (11.2 ng/dL) within 7 days of dietary modification.
* Final Diagnosis: Reversible Hyporeninemic Hypoaldosteronism and Hyperkalemia Secondary to Extreme Dietary Sodium (~100g) and Potassium (~12g) Overload (100%).

High-Yield Clinical Takeaways:
1. RAAS Hierarchy: Severe volume expansion (ANP elevation and Ang II absence) can override hyperkalemia-driven zona glomerulosa depolarization, completely suppressing aldosterone synthesis ($CYP11B2$) despite elevated serum potassium.
2. Aldosterone-Independent Kaliuresis: High distal sodium delivery and elevated tubular flow directly stimulate flow-sensitive BK (Maxi-K) channels and sustain ENaC-driven lumen-negative electrical gradients, facilitating massive potassium excretion without mineralocorticoids.
3. Excretion vs. Balance: Robust kaliuresis does not rule out potassium overload; 24-hour urinary excretion directly reflects steady-state dietary intake, which can still exceed maximal renal clearance capacity.
4. Diagnostic Pearl: 24-hour urinary sodium and potassium serve as an objective quantitative "dietary receipt." Extreme electrolyte abnormalities with intact renal function warrant a meticulous, targeted nutritional anamnesis before initiating invasive or expensive hormonal workups.

Attending:

Hello Attending Consultant here

Top 3 DDx:
1. Diet-induced reversible hyporeninemic hypoaldosteronism (NaCl/K overload)
2. Transient volume-expanded RAAS suppression (post-washout residual)
3. Occult secondary contributors (ruled out by full recovery)

Critique/Improvements (6 points):
- Affirm final Dx at 100%; rapid full RAAS/K normalization post-diet proves pure exogenous overload—no residual defect.
- Hierarchy insight: Volume/ANP-cGMP hyperpolarization + absent Ang-II extinguishes CYP11B2 despite K+ depolarization; intake cessation restores hierarchy instantly.
- Kaliuresis: Distal Na delivery + flow-activated BK/mTORC2-SGK1/ENaC fully compensate absent aldo, capping K at mild levels.
- Strengthen takeaway: 24-h urine electrolytes = quantitative intake assay; always precede endocrine panels in intact-GFR hyperK.
- Add: Educate on salt-dipping risks (HTN/edema rebound); recheck K/PRA only if symptoms recur—no chronic Rx.
- Avoid over-testing: Genetics/UFC unnecessary once reversible.
- Pearl: Extreme diet can mimic primary endocrine disease; history trumps labs.

Expert:

Hello, Expert Clinician here.

Final diagnosis: Reversible diet-induced hyperkalemia with volume-expanded, hyporeninemic hypoaldosteronism from extraordinary concurrent NaCl and potassium intake. Complete biochemical normalization after dietary withdrawal provides a strong dechallenge confirmation and excludes an intrinsic adrenal or renal defect.

Key pivot: The extreme 24-hour urinary sodium and potassium excretion revealed intake overload—not impaired filtration—as the driver.

Physiology
- Massive sodium loading expanded effective circulating volume, suppressing renin and angiotensin II while increasing natriuretic signaling. Loss of angiotensin-II support and direct ANP-mediated inhibition of zona-glomerulosa steroidogenesis outweighed potassium’s direct calcium-dependent stimulation of CYP11B2.
- High distal sodium delivery and tubular flow preserved potassium secretion despite low aldosterone. Basal ENaC activity created a lumen-negative potential, while flow and intracellular calcium activated BK channels; ROMK and aldosterone-independent signaling, including mTORC2–SGK1 pathways, contributed.
- Kaliuresis was robust but initially insufficient to match the exceptional potassium intake.

Alternatives now excluded: Primary adrenal insufficiency, intrinsic hypoaldosteronism, Gordon syndrome, and pseudohyperkalemia are inconsistent with rapid normalization of potassium, renin, aldosterone, and urinary electrolytes.

Management: Maintain ordinary sodium/potassium intake and periodically reassess blood pressure, potassium, and renal function; no further endocrine or genetic testing is indicated unless abnormalities recur.

Teaching pearl: High urinary potassium indicates excretion—not necessarily adequate potassium balance.

Top 15 Takeaways for Clinicians

  1. Volume Overload Overrides Potassium Stimulus: While hyperkalemia is classically a direct secretagogue for the adrenal zona glomerulosa, severe effective circulating volume expansion (via renin-angiotensin-II suppression and ANP release) dominates and shuts down CYP11B2 aldosterone synthesis.
  2. 24-Hour Urine Electrolytes as a "Dietary Receipt": In the presence of preserved GFR, 24-hour urinary sodium and potassium excretion provide an accurate quantitative assay of steady-state oral intake, unmasking surreptitious or extreme dietary habits.
  3. Robust Kaliuresis Does Not Rule Out Hyperkalemia: High urinary potassium excretion reflects massive intake-driven elimination rather than balanced clearance, and can still be outpaced by extreme gastrointestinal potassium absorption.
  4. Aldosterone-Independent Potassium Secretion: High distal sodium delivery and massive tubular flow activate flow-sensitive BK (Maxi-K) channels and preserve ENaC-mediated lumen-negative gradients, enabling significant kaliuresis without mineralocorticoids.
  5. Role of the mTORC2-SGK1 Pathway: Distal tubular potassium sensing can preserve ENaC activity and secretory channel function via mTORC2-SGK1 signaling independently of circulating plasma aldosterone levels.
  6. Normal GFR Does Not Equal Normal Homeostasis: Preserved glomerular filtration (eGFR > 120 mL/min/1.73 m²) does not protect against hyperkalemia if tubular secretory capacity is overwhelmed by massive oral electrolyte loading.
  7. Pseudohyperkalemia Exclusion Protocol: When assessing unexplained hyperkalemia, repeat potassium measurement on a free-flowing, non-tourniquet, non-hemolyzed whole blood/plasma sample processed promptly at 37°C to exclude familial red-cell leak defects.
  8. Dechallenge as Definitive Diagnostic Proof: Rapid, complete normalization of serum potassium, plasma renin activity, and aldosterone within 7 days of dietary correction definitively confirms an exogenous overload etiology and rules out intrinsic endocrinopathy.
  9. Pitfalls of Transcellular Assumptions: In an asymptomatic, normotensive patient with normal acid-base and glucose, transcellular potassium shifts (e.g., acidosis, insulin deficiency) are unlikely drivers compared to intake or tubular excretion defects.
  10. Avoid Premature Fludrocortisone Trials: Initiating mineralocorticoid replacement for suspected hypoaldosteronism in volume-expanded patients can precipitate fluid overload and severe hypertension; dietary washout should always come first.
  11. ANP-Mediated Adrenal Inhibition: Atrial natriuretic peptide (ANP) acts via the NPR-A/cGMP pathway in glomerulosa cells to hyperpolarize membranes and blunt calcium influx, directly antagonizing potassium-induced steroidogenesis.
  12. Culinary Habits as Hidden Etiologies: Specific food practices—such as dipping raw vegetables directly into heaps of table salt ("à la croque-au-sel") or consuming potassium-rich tomato diets—can deliver up to 100 g NaCl and 12 g K+ daily.
  13. Transtubular Potassium Gradient (TTKG) Limitations: A TTKG value (e.g., 7.8) must be interpreted in the context of plasma potassium; in severe hyperkalemia, a normal-appearing TTKG actually signifies inappropriately low aldosterone effect.
  14. Exclusion of Gordon Syndrome: Gordon syndrome (pseudohypoaldosteronism type II) also presents with hyperkalemia and low renin/aldosterone, but typically features hypertension and hyperchloremic metabolic acidosis, which were absent here.
  15. Comprehensive History Trumps Invasive Workups: Extreme electrolyte derangements with intact renal function warrant an exhaustive, nonjudgmental nutritional anamnesis before committing patients to expensive genetic sequencing or hormonal dynamic testing.